BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30663155)

  • 41. [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial].
    Sasako M; Saka M; Fukagawa T; Katai H; Sano T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():110-6. PubMed ID: 16897984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long term survival on S-1 monotherapy in a patient with recurrent stage IV pancreatic cancer.
    Alsamarai S; Zergebel C; Zhang J; Furuie T; Urrea PD; Saif MW
    JOP; 2008 Mar; 9(2):185-91. PubMed ID: 18326927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microcystic adnexal carcinoma: report of a case.
    Culhaci N; Copcu HE; Dikicioğlu E
    J Oral Maxillofac Surg; 2003 Jun; 61(6):723-5. PubMed ID: 12796886
    [No Abstract]   [Full Text] [Related]  

  • 44. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.
    Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M;
    Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microcystic adnexal carcinoma.
    Adamson T
    Dermatol Nurs; 2004 Aug; 16(4):365. PubMed ID: 15471052
    [No Abstract]   [Full Text] [Related]  

  • 46. [Successful monotherapy with S-1 in three cases of recurrent/advanced breast cancer non-responsive to anthracycline and taxane anticancer drugs].
    Sato N; Sano M
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):137-40. PubMed ID: 16410715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil and oteracil potassium) for colorectal cancer.
    Kawahara H; Watanabe K; Ushigome T; Noaki R; Kobayashi S; Yanaga K
    Hepatogastroenterology; 2012; 59(113):134-7. PubMed ID: 22251528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of advanced gastric cancer with histological complete response after S-1 chemotherapy].
    Yahara N; Hayashi H; Furuya T; Saeki T; Hayashi H; Inoue Y; Yanai H; Ishigaki N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2300-2. PubMed ID: 20037402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microcystic adnexal carcinoma (sclerosing sweat duct carcinoma).
    Lober CW; Larbig GG
    South Med J; 1994 Feb; 87(2):259-62. PubMed ID: 8115895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral fluoropyrimidines in colorectal cancer.
    Van Cutsem E; Peeters M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
    [No Abstract]   [Full Text] [Related]  

  • 51. Adjuvant S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma.
    Shinkawa H; Uenishi T; Takemura S; Sakata C; Urata Y; Nozawa A; Hamano G; Kinoshita M; Kubo S
    Hepatogastroenterology; 2015; 62(137):169-74. PubMed ID: 25911890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral treatment for gastric cancer: new choices, better choices?
    Cascinu S
    Lancet Oncol; 2008 Mar; 9(3):188-9. PubMed ID: 18308239
    [No Abstract]   [Full Text] [Related]  

  • 53. Ductal eccrine carcinoma of the axilla: a diagnostic pitfall.
    Brito MHTS; Dionísio CSNM; Ferreira JCM; Rosa MJMPMDC; Cunha FPBE; Garcia MMAPDS
    An Bras Dermatol; 2017; 92(2):239-242. PubMed ID: 28538887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Raising the bar for the adjuvant treatment of pancreatic cancer.
    Ko AH
    Lancet; 2016 Jul; 388(10041):214-5. PubMed ID: 27265348
    [No Abstract]   [Full Text] [Related]  

  • 55. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
    Kobayashi A; Yamaguchi M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Microcystic adnexal carcinoma: A case report].
    Jean-Jacques B; Michels JJ; Veyssiere A; Haidar D
    Ann Pathol; 2018 Jun; 38(3):198-201. PubMed ID: 29622469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
    Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():144-9. PubMed ID: 16897991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microcystic adnexal carcinoma: the first reported congenital case.
    Smart DR; Taintor AR; Kelly ME; Lyon VB; Segura A; Jensen JN; Drolet BA
    Pediatr Dermatol; 2011; 28(1):35-8. PubMed ID: 21276051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A case of recurrent gastric cancer successfully treated with S-1 oral administration].
    Maeda H; Okamoto K; Sakamoto J; Usui T; Kawamura A; Tamura S; Takeshita A; Kobayashi M
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):89-92. PubMed ID: 25596686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A case of advanced gastric cancer effectively treated by TS-1 for 4 years].
    Ogino H; Misawa T; Nasu T; Ihara Y; Kubo S; Sadamoto Y; Harada N; Nakamura K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):833-6. PubMed ID: 15984526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.